Cargando…

Autophagy and multidrug resistance in cancer

Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting MDR is an important issue. Autophagy, a self-degradative system, universally arises during the treatment of sensitive and MDR cancer. Autophagy can be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ying-Jie, Lei, Yu-He, Yao, Nan, Wang, Chen-Ran, Hu, Nan, Ye, Wen-Cai, Zhang, Dong-Mei, Chen, Zhe-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482965/ https://www.ncbi.nlm.nih.gov/pubmed/28646911 http://dx.doi.org/10.1186/s40880-017-0219-2

Ejemplares similares

Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistance
por: Huang, Bao-Yuan, et al.
Publicado: (2017)

Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
por: Zhang, Lei, et al.
Publicado: (2023)

Multidrug resistance associated proteins in multidrug resistance
por: Sodani, Kamlesh, et al.
Publicado: (2012)

A piperazidine derivative of 23-hydroxy betulinic acid induces a mitochondria-derived ROS burst to trigger apoptotic cell death in hepatocellular carcinoma cells
por: Yao, Nan, et al.
Publicado: (2016)

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
por: HUANG, FANG, et al.
Publicado: (2014)

BBA, a Synthetic Derivative of 23-hydroxybutulinic Acid, Reverses Multidrug Resistance by Inhibiting the Efflux Activity of MRP7 (ABCC10)
por: Chen, Jun-Jiang, et al.
Publicado: (2013)

Involvement of Actin in Autophagy and Autophagy-Dependent Multidrug Resistance in Cancer
por: Izdebska, Magdalena, et al.
Publicado: (2019)

AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer
por: Liu, Kun, et al.
Publicado: (2021)

Autophagy and Transporter-Based Multi-Drug Resistance
por: Kumar, Priyank, et al.
Publicado: (2012)

Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
por: Lee, Nan-Yao, et al.
Publicado: (2019)

Inhibition of PINK1/Parkin-dependent mitophagy sensitizes multidrug-resistant cancer cells to B5G1, a new betulinic acid analog
por: Yao, Nan, et al.
Publicado: (2019)

Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)
por: Shen, Tong, et al.
Publicado: (2009)

Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells
por: Zhang, Lei, et al.
Publicado: (2022)

Correction: Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)
por: Shen, Tong, et al.
Publicado: (2009)

Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10)
por: DENG, WEN, et al.
Publicado: (2013)

Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance
por: Abraham, Ioana, et al.
Publicado: (2012)

Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters
por: Zhang, Yun-Kai, et al.
Publicado: (2016)

Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study
por: Ji, Ning, et al.
Publicado: (2019)

Research Progress and Prospects of Autophagy in the Mechanism of Multidrug Resistance in Tumors
por: Long, Wenqing, et al.
Publicado: (2022)

Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar
por: Sun, Yue-Li, et al.
Publicado: (2013)

TPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer
por: Song, Jie, et al.
Publicado: (2015)

The antibiotic resistance and pathogenicity of a multidrug‐resistant Elizabethkingia anophelis isolate
por: Wang, Mingxi, et al.
Publicado: (2019)

Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China
por: Zhao, Jiang-nan, et al.
Publicado: (2015)

Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression
por: Liao, Dan, et al.
Publicado: (2019)

p53-Induced Autophagy Regulates Chemotherapy and Radiotherapy Resistance in Multidrug Resistance Cancer Cells
por: Ma, Shumei, et al.
Publicado: (2021)

Lipid–Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo
por: Zhang, Guan-Nan, et al.
Publicado: (2020)

Establishment and Characterization of a Novel Multidrug Resistant Human Ovarian Cancer Cell Line With Heterogenous MRP7 Overexpression
por: Wang, Jing-Quan, et al.
Publicado: (2021)

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
por: Ji, Ning, et al.
Publicado: (2018)

The Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative Bacilli
por: Zhao, Jiang-nan, et al.
Publicado: (2015)

Reversal effect and mechanism of Ginkgo biloba exocarp extracts in multidrug resistance of mice S180 tumor cells
por: Hu, Bi-Yuan, et al.
Publicado: (2016)

Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation
por: Wu, Jian, et al.
Publicado: (2018)

Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells
por: Dong, Xing-Duo, et al.
Publicado: (2020)

Klebsiella species: Taxonomy, hypervirulence and multidrug resistance
por: Dong, Ning, et al.
Publicado: (2022)

Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter
por: Qiu, Jian-Ge, et al.
Publicado: (2015)

Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells
por: Cui, Qingbin, et al.
Publicado: (2019)

MicroRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR axis in gastric cancer
por: Chen, Sheng, et al.
Publicado: (2018)

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
por: Zhang, Wei, et al.
Publicado: (2018)

Multidrug Resistance of Gastric Cancer: The Mechanisms and Chinese Medicine Reversal Agents
por: Huang, Wen-Jie, et al.
Publicado: (2020)

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line
por: Li, Jie, et al.
Publicado: (2001)

Clinical and Computed Tomography Features Associated with Multidrug-Resistant Pulmonary Tuberculosis: A Retrospective Study in China
por: Li, Chun-Hua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_22uf67r297sidd3iq5irimgob9